- Home
- JMSB vs ALDX Comparison
JMSB vs ALDX Comparison
Compare JMSB & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JMSB | ALDX |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.3M | 317.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JMSB | ALDX |
|---|---|---|
| Price | $20.10 | $5.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $22.50 | $9.50 |
| AVG Volume (30 Days) | 19.9K | ★ 776.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.30 | N/A |
| Revenue Next Year | $9.72 | $36.25 |
| P/E Ratio | $13.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.81 | $1.14 |
| 52 Week High | $21.58 | $7.20 |
Technical Indicators
Market Signals| Indicator | JMSB | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 50.79 |
| Support Level | $19.89 | $5.04 |
| Resistance Level | $21.20 | $5.56 |
| Average True Range (ATR) | 0.45 | 0.34 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 29.39 | 27.72 |
Price Performance
Historical ComparisonAbout JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.